Trial intelligence / Profile preview

FOLFOX7 and Chemoradiotherapy for Recurrent Ganglionic Colorectal Cancer

NCT00268333Phase 2Completed

Sponsor
GERCOR
Start
Aug 2005
Primary completion
Jan 2006
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in colorectal cancer (CRC), sponsored by GERCOR. Started Aug 2005; status: completed.

02

Drugs

oxaliplatinfluorouracilfolinic acid
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00268333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00268333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call